Enhancing the production of adeno‐associated virus (AAV)2 and AAV9 with high full capsid ratio in HEK293 cells through design‐of‐experiment optimization of triple plasmid ratio
Biotechnology Journal · 2024-03 · 19 (3)
DOI: 10.1002/biot.202300667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 13.03.2024. Verfasst von Sungje Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, KAIST, Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: Capsid, Parvovirinae. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
The recombinant adeno‐associated virus (rAAV) vectors used in gene therapy are usually produced by transfecting three different plasmids (Adenoviral helper plasmid (pHelper), AAV rep/cap plasmids (pRepCap), and Transgene plasmid (pAAV‐GOI)) into human embryonic kidney 293 (HEK293) cells. However, the high proportion of unwanted empty capsids generated during rAAV production is problematic. To simultaneously enhance the genome titer and full capsid ratio, the ratio of the three plasmids transfected into HEK293 cells was optimized using design‐of‐experiment (DoE). AAV2 and AAV9, which have different production kinetics, were selected as cell‐associated and secreted model AAVs, respectively. In 125 mL Erlenmeyer flasks, the genome titers of rAAV2 and rAAV9 at DoE‐optimized plasmid weight ratios (pHelper:pRep2Cap2:pAAV‐GOI = 1:3.52:0.50 for rAAV2 and pHelper:pRep2Cap9:pAAV‐GOI = 1:1.44:0.27 for rAAV9) were 2.23‐fold and 2.26‐fold higher than those in the widely used plasmid weight ratio (1:1:1), respectively. In addition, compared with the plasmid ratio of 1:1:1, the relative VP3 band intensities of rAAV2 and rAAV9, which represent the relative empty capsid ratios, were reduced by 26% and 25%, respectively, at the DoE‐optimized plasmid ratio. Reduced empty capsid ratios in the DoE‐optimized plasmid ratios were also confirmed using transmission electron microscopy (TEM). Taken together, regardless of the AAV serotype, DoE‐aided optimization of the triple plasmid ratio was found to be an efficient means of improving the production of rAAV with a high full capsid ratio.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, KAIST, Daejeon, Republic of Korea.
- Department of Chemistry, KAIST, Daejeon, Republic of Korea.
- Department of Chemical and Biomolecular Engineering, Yonsei University, Seoul, Republic of Korea.
- R&D Center, GluGene Therapeutics Inc., Seoul, Republic of Korea.
ORCID-Profile: Seunghyeon Shin, Gyun Min Lee
Zitieren
APA
Park, S., Shin, S., Lee, H., Jang, J. H., & Lee, G. M. (2024). Enhancing the production of adeno‐associated virus (AAV)2 and AAV9 with high full capsid ratio in HEK293 cells through design‐of‐experiment optimization of triple plasmid ratio. Biotechnology Journal, 19(3). https://doi.org/10.1002/biot.202300667
Vancouver
Park S, Shin S, Lee H, Jang JH, Lee GM. Enhancing the production of adeno‐associated virus (AAV)2 and AAV9 with high full capsid ratio in HEK293 cells through design‐of‐experiment optimization of triple plasmid ratio. Biotechnology Journal. 2024;19(3). doi:10.1002/biot.202300667
BibTeX
@article{Park2024,
author = {Park, Sungje and Shin, Seunghyeon and Lee, Haeshin and Jang, Jae-Hyung and Lee, Gyun Min},
title = {Enhancing the production of adeno‐associated virus (AAV)2 and AAV9 with high full capsid ratio in HEK293 cells through design‐of‐experiment optimization of triple plasmid ratio},
journal = {Biotechnology Journal},
year = {2024},
volume = {19},
number = {3},
doi = {10.1002/biot.202300667}
}
EUVIMED